Kenichi Chikamori
- Oncology top 5%
- Lung Cancer Research Studies 17
- Colorectal Cancer Treatments and Studies 8
-
- Lung Cancer Treatments and Mutations 20
- Lung Cancer Diagnosis and Treatment 7
- Gastric Cancer Management and Outcomes 3
- Toxicology top 10%
-
- Cancer therapeutics and mechanisms 12
-
- Neuroendocrine Tumor Research Advances 3
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Toshiyuki KozukiMahrukh K. GanapathiRam GanapathiDale GrabowskiKatsuyuki KiuraKeisuke AoeHiroshi UeokaMitsune Tanimoto
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kenichi Chikamori
39 papers receiving 797 citations
Peers
Comparison fields: 5 of 69
- Oncology 502
- Pulmonary and Respiratory Medicine 423
- Toxicology 23
- Molecular Biology 386
- Cancer Research 65
Countries citing papers authored by Kenichi Chikamori
This map shows the geographic impact of Kenichi Chikamori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Chikamori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Chikamori more than expected).
Fields of papers citing papers by Kenichi Chikamori
This network shows the impact of papers produced by Kenichi Chikamori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Chikamori. The network helps show where Kenichi Chikamori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenichi Chikamori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 0 | |
| 6 | 2018 | 20 | |
| 7 | 2017 | 123 | |
| 8 | 2017 | 23 | |
| 9 | 2017 | 6 | |
| 10 | 2016 | 8 | |
| 11 | 2015 | 86 | |
| 12 | 2014 | 3 | |
| 13 | 2013 | 76 | |
| 14 | 2011 | 3 | |
| 15 | 2010 | 79 | |
| 16 | 2008 | 29 | |
| 17 | 2008 | 11 | |
| 18 | 2006 | 25 | |
| 19 | 2003 | 53 | |
| 20 | 1997 | 3 |
About Kenichi Chikamori
Kenichi Chikamori is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Toxicology, having authored 43 papers that have together received 812 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (17 papers), Cancer therapeutics and mechanisms (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Neuroendocrine Tumor Research Advances (3 papers), Gastric Cancer Management and Outcomes (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Oncology (502 citations), Pulmonary and Respiratory Medicine (423 citations) and Toxicology (23 citations). Kenichi Chikamori has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Toshiyuki Kozuki, Mahrukh K. Ganapathi, Ram Ganapathi, Dale Grabowski, Katsuyuki Kiura, Keisuke Aoe, Hiroshi Ueoka, Mitsune Tanimoto, Naoyuki Nogami and Katsuyuki Hotta. Their work appears in journals such as Annals of Oncology, Lung Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.